Risk factors associated with adverse outcome following extracorporeal life support: analysis from 360 consecutive patients

Abstract

Objective:

Risk factors for adverse outcome after extracorporeal life support (ECLS) are yet to be defined. For this purpose, we reviewed our institutional data from more than a decade, focusing on patients with ECLS.

Methods:

Between December 2001 and June 2013, 360 consecutive cardiac surgical patients received ECLS for post-cardiotomy cardiogenic shock, with high mortality risk despite optimal conventional therapy. Patient demographics, clinical characteristics, ECLS-related morbidity, as well as in-hospital and long-term mortality were analysed. Multivariate logistic regression analysis was performed to identify independent predictors of adverse outcome (failed ECLS weaning, in-hospital mortality).

Results:

The mean age was 62±17 years, 76% were male and the mean preoperative ejection fraction was 35±16%. ECLS was established through peripheral (90%) or central thoracic cannulation. The mean duration of ECLS was 7±1 days. Intra-aortic balloon pumps were implanted in 22% of the patients. ECLS weaning was successful in 58% and 30% could be discharged from hospital. The main cause of death was sepsis (69%). Overall, major cerebrovascular events occurred in 12% (bleeding 3%, embolic 9%), limb ischaemia in 13%, gastrointestinal complications in 16% and renal replacement therapy in 61%. Independent risk factors for adverse outcome were prior cardiorespiratory resuscitation (OR: 4.1, 95%CI: 0.34-4.21, p=0.04), pH <7.1 (OR: 2.8, 95%CI: 0.45-3.28, p=0.01), serum lactate >120 mg/dL (OR: 2.6, 95%CI: 0.75-2.96, p< 0.01), norepinephrine dosage >0.5 µg/kg/min (OR: 2.4, 95%CI: 0.35-2.92, p=0.02) and age >75 years (OR: 2.0, 95%CI: 0.41-2.88, p=0.02). Kaplan Meier estimates for long-term survival were 26±3% at one year and 22±2% at five years.

Conclusion:

ECLS therapy offers one-year survival to one quarter of patients with an otherwise fatal prognosis. Procedural mortality is low and morbidity at the implantation site typically moderate. Thus, prolonged metabolic deterioration in combination with high-dose vasopressor support prior to ECLS therapy should be avoided, particularly in younger patients.

Keywords

extracorporeal life support post-cardiotomy cardiogenic shock mechanical circulatory support adult cardiac surgery intensive care unit

Get full access to this article

View all access options for this article.

References

Doll

Kiaii

Borger

. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg 2004; 77: 151–157.

Smedira

Moazami

Golding

. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. J Thorac Cardiovasc Surg 2001; 122: 92–102.

Golding

LAR

. Postcardiotomy mechanical support. Semin Thorac Cardiovasc Surg 1991; 3: 29–33.

Lin

Chen

Wang

Lin

Chen

. Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. Ann Thorac Surg 2002; 73: 538–545.

Pagani

Aaronson

Swaniker

Bartlett

. The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device. Ann Thorac Surg 2001; 71: 77–85.

Extracorporeal Life Support Organization. Ann Arbor (MI): The Organization; [published 2009, cited 2009]. Available from: http://www.elso.med.umich.edu/.

Magovern

Jr Simpson

. Extracorporeal membrane oxygenation for adult cardiac support: the Allegheny experience. Ann Thorac Surg 1999; 68: 655–661.

Bakhtiary

Keller

Dogan

. Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: clinical experiences in 45 adult patients. J Thorac Cardiovasc Surg 2008; 135: 382–388.

Smedira

Blackstone

. Postcardiotomy mechanical support: risk factors and outcomes. Ann Thorac Surg 2001; 71: 82–85.

10.

Papadopoulos

Ahmad

Ael-S

Marinos

Moritz

Zierer

. Extracorporeal membrane oxygenation for influenza-associated acute respiratory distress syndrome. Ann Thorac Surg 2013; 61: 516–521.

11.

Papadopoulos

Ahmad

Marinos

Moritz

Zierer

. Simple and controlled method to avoid hyperperfusion of the right arm following axillary artery cannulation for extracorporeal membrane oxygenator support. J Thorac Cardiovas Surg 2013; 61: 581–583.

12.

Hill

O’Brien

Murray

. Prolonged extracorporeal oxygenation of acute posttraumatic respiratory failure (shock-lung syndrome). N Engl J Med 1972; 286: 629–634.

13.

Paden

Conrad

Rycus

Thiagarajan

; ELSO Registry. Extracorporeal Life Support Organization Registry Report 2012. ASAIO J 2013; 59: 202–210.

14.

Mendiratta

Wei

Gomez

. Cardiopulmonary resuscitation requiring extracorporeal membrane oxygenation in the elderly: a review of the Extracorporeal Life Support Organization registry. ASAIO J 2013; 59: 211–215.

15.

Susan

E. Coffin

Louis

. Nosocomial infections in neonates receiving extracorporeal membrane oxygenation. Infection Control and Hospital Epidemiology 1997; 18: 93–96.

16.

Hsu

Chiu

Huang

. Risk factors for nosocomial infection during extracorporeal membrane oxygenation. J Hosp Infect 2009; 73: 210–216.

17.

O’Neil

Schutze

Heulitt

. Nosocomial infections during extracorporeal membrane oxygenation. Intensive Care Med 2001; 27: 1247–1253.

18.

Kao

Fleming

Escamilla

. Antimicrobial prophylaxis and infection surveillance in extracorporeal membrane oxygenation patients: a multi-institutional survey of practice patterns. ASAIO J 2011; 57: 231–238.

19.

Rastan

Dege

Mohr

. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg 2010; 139: 302–311.

20.

Chen

Lin

. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet 2008; 372: 554–561.

21.

Chen

Chao

. Analysis and results of prolonged resuscitation in cardiac arrest patients rescued by extracorporeal membrane oxygenation. J Am Coll Cardiol 2003; 41: 197–203.

22.

Schwarz

Mair

Margreiter

. Experience with percutaneous venoarterial cardiopulmonary bypass for emergency circulatory support. Crit Care Med 2003; 31: 758–764.

23.

Golding

Crouch

Stewart

. Postcardiotomy centrifugal mechanical ventricular support. Ann Thorac Surg 1992; 54: 1059–1064.

24.

Muehrcke

McCarthy

Stewart

. Complications of extracorporeal life support systems using heparin-bound surfaces. The risk of intracardiac clot formation. J Thorac Cardiovasc Surg 1995; 110: 843–851.